>
Mamdani just showed his true 'Bolshevik' colors…
Everyone Is Watching the Wrong Bubble
LIVE Coverage Of Exploding Cyber Attacks! FBI Main Database Hacked, Trump Says It Will Expose...
Dubai Just Finished the World's First Permanent Air Taxi Route: Airport to the Marina in Under 1
Doroni Aerospace Raises More than $60m for H1?X Development
After 13 Years Battling Cancer, a 61-Year-Old Brazilian Man Achieved Complete Remission...
Extraterrestrial habitats may rise via Legos of laser-fused moon dust
Battery-only 19-seater puts China in the electric airliner race
Dream Chaser space plane gets landing approval for debut mission in 2027
SpaceX Just Caught Starship on Its FIRST Attempt!
Solid-State Cells Can Make The U.S. Competitive In Batteries Again: CEO
Jetson ONE personal eVTOL pod is about to go full sky patrol
America's INSANE BREAKTHROUGH Could Replace Septic Tanks Forever

Full regeneration and immortalized cells exists in humans two weeks after conception.
There is work to re-activate those capabilities with adult cells.
The video and screenshots below are from the the CEO of AgeX Dr Michael West and another with Michael West talking with Dr. Aubrey de Grey, V.P. New Technology Discovery.
AgeX Therapeutics is a biotechnology company formed in 2017 as a subsidiary of BioTime, Inc (NYSE MKT: BTX). Its mission is to apply technology related to cell immortality and pluripotency to human aging and age-related disease. The Company's technology platform has three facets: Pluripotent stem cell-derived progenitor cell lines representing over 200 types of cells in the body (PureStem technology); HyStem matrices; and induced tissue regeneration (iTR) – the latter being an emerging technology directed at inducing the immortal regeneration of tissues in the body.